We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Projects granted during 2015 that have a primary purpose of basic research: immune system.
VDEC responds strategically to AMR pathogens and new emerging threats (fungi, viruses, and bacteria), by determining the most appropriate research goals to combat these pathogens
This study investigates the impact that adsorptive mutation and N-linked glycosylation have on receptor-binding, viral fitness, and antigenicity
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How an innovative funding mechanism is saving lives by speeding up the availability of vaccines and making them affordable.
Information for public health professionals about how vaccines work.
Projects granted during 2015 that have a primary purpose of translational and applied research: human immune disorders.
Projects granted during 2016 that have a primary purpose of basic research, immune system.
VDEC developed a standardised assay reduce the development of antimicrobial resistance and improve patient treatment for tuberculosis.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).